Atlas Trials

An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

Clinical trial NCT05876754 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05876754
Sponsor
Servier Affaires Médicales
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Cholangiocarcinoma
Start date
2023-05-03
Primary completion
2027-12-01
Enrollment
299

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.